Disc Medicine
NASDAQ: IRON170 employees on LinkedIn · 14 known investors
Disc Medicine is a biopharmaceutical company developing therapies from discovery through clinical development for patients in need. It is led by a team of scientists and industry veterans across chemistry, clinical development, and medical affairs.
Founders & leadership
JQ
John QuiselinChief Executive Officer
JF
Jean FranchiinChief Financial Officer
JY
Jonathan YuinChief Operating Officer
WS
Will SavageinChief Medical Officer
PS
Pamela StephensoninChief Commercial Officer
SC
Steve CafféinChief Regulatory Officer
RR
Rahul Rajan KaushikinChief Technical Officer
RK
Rahul KharainChief Legal Officer
LA
Lisa Amaya PriceinChief Human Resources Officer
HY
Hua YanginChief Early Development Officer
Investors · 14
Access BiotechnologyNew York City
Atlas VentureCambridge · $500K – $1M
Bain Capital Life SciencesBoston
Foresite CapitalWest Hollywood
Frazier Life SciencesPalo Alto
OrbiMedNew York · $1M – $75M
5AM VenturesreportedBoston · $100K – $4M
AlexandriareportedPasadena
Arix BiosciencereportedLondon
Janus Henderson InvestorsreportedNew York
Novo HoldingsreportedCopenhagen · $1.1M – $54M
Rock Springs CapitalreportedBaltimore
Willett AdvisorsreportedNew York
Also in the syndicate · 1
Nantahala Capital Management
Funding
SEC filings, press & company announcements- Undisclosed amountseries BSep 2021
OrbiMed (lead), 5AM Ventures, Access Biotechnology, Alexandria Venture Investments, Arix Bioscience, Atlas Venture, Janus Henderson Investors, Nantahala Capital Management, Novo Holdings, Rock Springs Capital, Willett Advisors
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlapBioworld30 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Seeking Alpha26 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies competing with Disc Medicine for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Disc Medicine faces class action after FDA reje... | Pluangpluang.com · Aug 2026Frequently asked questions
- What does Disc Medicine do?
- Disc Medicine is a biopharmaceutical company developing therapies from discovery through clinical development for patients in need. It is led by a team of scientists and industry veterans across chemistry, clinical development, and medical affairs.
- Who are Disc Medicine's investors?
- Disc Medicine's investors include Access Biotechnology, Atlas Venture, Bain Capital Life Sciences, Foresite Capital, Frazier Life Sciences, OrbiMed, 5AM Ventures, Alexandria and 5 more.